Key result
Angiotensin II type 1 receptor antagonists effectively lower blood pressure by blocking AII-mediated actions.
Why the study?
Angiotensin II type 1 receptor antagonists are a new pharmacologic class designed to treat essential hypertension and hypertensive patients with intrinsic renal disease, requiring review of their pharmacology and clinical effects.
Answers are grounded in this paper and cite their sources.
Angiotensin II type 1 receptor antagonists represent a new class of antihypertensive drugs that are effective for treating essential hypertension and hypertensive renal disease.
The angiotensin II (AII) type 1 receptor antagonists represent a new pharmacologic class of drugs that are specifically designed to displace AII from its type 1 receptor subtype. These drugs antagonize AII-induced biologic actions, including smooth-muscle contraction, sympathetic pressor mechanisms, and aldosterone release. Initial clinical trials suggest that these drugs are effective in the treatment of essential hypertension and hypertensive patients with intrinsic renal disease. Thus, they are the newest addition to the therapeutic armamentarium for the treatment of hypertensive diseases. We review the developmental history and pharmacology of the AII type 1 receptor antagonists. We specifically discuss the following factors: mechanism(s) of action; members under clinical investigation; effects on renal function, salt and water excretion, and plasma renin activity, plasma AII type 1, and plasma aldosterone concentrations; and efficacy and safety. Given the demonstrable benefits of AII type 1 receptor blockade, these drugs should achieve broad utility in the treatment of hypertensive diseases.
No takes yet. Share an insight, caveat, or question.
J. H. Bauer (1995) conducted a review in Essential hypertension and hypertensive patients with intrinsic renal disease. Angiotensin II type 1 receptor antagonists was evaluated. Angiotensin II type 1 receptor antagonists are a new class of antihypertensive drugs that effectively antagonize AII-induced biologic actions and show efficacy in treating hypertensive diseases.
Synapse has enriched 10 related papers. Consider them for comparative context: